KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Travere Therapeutics (TVTX) Tax Rate (2016 - 2025)

Historic Tax Rate for Travere Therapeutics (TVTX) over the last 12 years, with Q3 2025 value amounting to 0.03%.

  • Travere Therapeutics' Tax Rate fell 1200.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.04% for FY2024, which is 200.0% up from last year.
  • Per Travere Therapeutics' latest filing, its Tax Rate stood at 0.03% for Q3 2025, which was down 1200.0% from 0.16% recorded in Q2 2025.
  • Travere Therapeutics' 5-year Tax Rate high stood at 0.15% for Q3 2024, and its period low was 0.58% during Q1 2021.
  • In the last 5 years, Travere Therapeutics' Tax Rate had a median value of 0.08% in 2023 and averaged 0.09%.
  • Its Tax Rate has fluctuated over the past 5 years, first tumbled by -1051600bps in 2021, then surged by 5200bps in 2022.
  • Over the past 5 years, Travere Therapeutics' Tax Rate (Quarter) stood at 0.0% in 2021, then crashed by -1534bps to 0.07% in 2022, then fell by -4bps to 0.08% in 2023, then soared by 255bps to 0.12% in 2024, then crashed by -74bps to 0.03% in 2025.
  • Its last three reported values are 0.03% in Q3 2025, 0.16% for Q2 2025, and 0.09% during Q1 2025.